Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 52.30
-0.70 (-1.32%)
Sep 24, 2026, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 883.34 million as of September 24, 2026. Its market cap has decreased by -66.09% in one year.
Market Cap
883.34M
Enterprise Value
848.14M
Revenue
250.30M
Ranking
n/a
PE Ratio
57.56
Stock Price
52.30
ChartMarket Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has decreased from 1.35B to 883.34M, a decrease of -34.65%. That is a compound annual growth rate of -8.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 883.34M | -53.55% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BICO Group AB | 1.58B |
| Paxman AB | 1.39B |
| C-Rad AB | 1.16B |
| Sedana Medical AB | 943.70M |
| Episurf Medical AB | 843.32M |
| Bactiguard Holding AB | 564.21M |
| BrainCool AB | 425.68M |
| Senzime AB | 420.55M |